DYNAVAX TECHNOLOGIES CORP Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Amortization of right-of-use assets
Inventory write-off
Loss (gain) on disposal of property and equipment and from lease termination
Sublease termination loss (Note 8)
Amortization of premiums (accretion of discounts) on marketable securities
Realized gain on available-for-sale securities
Loss on debt extinguishment
Change in fair value of warrant liability
Stock-based compensation expense
Cost of sales - amortization of intangible assets
Non-cash interest expense
Tenant improvements provided by the landlord
Gain on sale of assets
Bad debt expense (Note 9)
Changes in operating assets and liabilities:
Accounts and other receivables, net
Inventories
Prepaid manufacturing
Prepaid expenses and other current assets
Other assets
Accounts payable
CEPI accrual (Note 9)
Lease liabilities
Deferred revenue
Accrued and other liabilities
Net cash provided by operating activities
Investing activities
Acquisition of technology licenses
Purchases of marketable securities
Proceeds from maturities and redemptions of marketable securities
Proceeds from sales of marketable securities
Purchases of property and equipment, net
Proceeds from sale of assets, net of transaction costs
Net cash used in investing activities
Financing activities
Proceeds from issuances of common stock, net
Proceeds from issuance of Convertible Notes, net
Purchases of capped call options
Repayment of long-term debt
Payments for repurchase of common stock
Proceeds from warrants exercises
Proceeds from exercise of stock options and/or release of restricted stock awards, net
Proceeds from Employee Stock Purchase Plan
Payments for taxes related to net share settlement of RSUs
Net cash (used in) provided by financing activities
Effect of exchange rate changes on cash and cash equivalents, and restricted cash
Net decrease in cash and cash equivalents, and restricted cash
Cash and cash equivalents, and restricted cash at beginning of year
Cash and cash equivalents, and restricted cash at end of year
Supplemental disclosure of cash flow information
Cash paid during the year for income taxes
Cash paid during the year for interest
Reclassification of contract asset from other current assets to other assets
Reclassification of CEPI accrual to CEPI accrual long-term
Advance Payments forgiven per CEPI-Bio E Assignment Agreement (Note 9)
Non-cash investing and financing activities:
Purchases of property and equipment, not yet paid
Right-of-use assets obtained in exchange for operating lease liabilities

Comments